Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Trial for Enhanced Trained Immune Responses Through Bacillus Calmette-Guérin Vaccination to Prevent Infections by COVID-19: The ACTIVATE II Trial

NCT04414267 is registered in ClinicalTrials.gov with Hellenic Institute for the Study of Sepsis as lead sponsor.

NCT NCT04414267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04414267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Trial for Enhanced Trained Immune Responses Through Bacillus Calmette-Guérin Vaccination to Prevent Infections by COVID-19: The ACTIVATE II Trial
Lead sponsor
Hellenic Institute for the Study of Sepsis
Phase
Phase 4
Overall status
Completed
Start date
May 26, 2020
Completion date
May 7, 2021
Enrollment
301 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, corona virus infection, coronary heart disease, covid-19, virus diseases